Buyout A big pharma may take a run at us, but won't likely be straight up buyout offer. I see a buyout offer for xx and a further sum of xxx once FDA approval happens. 800mm worldwide peak revenue potential as per the new website will have a few pharmas licking their chops. If a suitor waited until FDA approval in place we'd be looking at a billion + takeout range. Much cheaper to take a run at us now with a bonus once FDA approves MCNA. I know Endo has experience in these types of structured buyouts, my guess is valeant does as well. JMHO.
beech